Home › Sindrome da bronchiolite obliterante › Washington › Seattle
Studi clinici su Sindrome da bronchiolite obliterante a Seattle, WA
11 studi su Sindrome da bronchiolite obliterante cercano partecipanti presso sedi a Seattle e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
In reclutamentoFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
In reclutamentoFase 2
- Fred Hutchinson Cancer Research Center- Site Number : 8400002, Seattle
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
In reclutamentoFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
In reclutamentoFase 2
- Fred Hutchinson Cancer Research Center, Seattle
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
In reclutamentoFase 2
- Seattle Childrens Hospital, Seattle
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
In reclutamentoStudio osservazionale
- Fred Hutchinson Cancer Research Center, Seattle
Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
In reclutamento
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
In reclutamentoFase 2
- Fred Hutchinson Cancer Research Center, Seattle
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
In reclutamentoFase 2
- Fred Hutchinson Cancer Center, Seattle
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
In reclutamentoFase 3
- Fred Hutchinson Cancer Research Center, Seattle
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
In reclutamentoFase 1
- Fred Hutchinson Cancer Center, Seattle
Studi su Sindrome da bronchiolite obliterante in altre città
- Boston, MA13 studi
- Atlanta, GA10 studi
- New York City, NY9 studi
- Houston, TX8 studi
- Los Angeles, CA7 studi
- Miami, FL7 studi
- Baldwin Park, CA6 studi
- Tampa, FL6 studi
- Durham, NC6 studi
- Philadelphia, PA6 studi
- Washington, DC6 studi
- Chicago, IL5 studi
Altri studi a Seattle
- Cancro del polmone non a piccole cellule53 studi
- Cancro (tutti i tipi)49 studi
- Cancro alla prostata42 studi
- Leucemia mieloide acuta40 studi
- Cancro al seno39 studi
- Cancro metastatico39 studi
- Cancro colorettale34 studi
- Cancro ai polmoni33 studi
- Cancro ovarico30 studi
- Mieloma multiplo22 studi
- Sindromi mielodisplastiche21 studi
- Leucemia linfoblastica acuta21 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.